MedTrace Logo

Cardiac Biomarkers in Patients With Single Ventricle Physiology

NCT03678909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2020-08-03

No results posted yet for this study

Summary

All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-type natriuretic peptide (BNP) and Troponin level before the surgical procedure, on arrival to the cardiac intensive care unit after their surgical procedure, every 6 hours during the first 24 hours of the post-operative period, followed by daily levels for the first week, and then weekly during patient's regular laboratory work up schedule.

These cardiac biomarkers are linked to demographic, hemodynamic, respiratory, pharmacological data available via Sickbay.

Conditions

  • Hypoplastic Left Heart
  • Congenital Heart Disease
  • Cyanotic Congenital Heart Disease
  • Cardiac Disease

Interventions

PROCEDURE

Norwood Palliation / DKS / Damus-Kaye-Stansel procedure

Norwood Palliation / DKS / Damus-Kaye-Stansel procedure

Sponsors & Collaborators

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Marc M Anders, ND · Baylor College of Medicine

Eligibility

Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-06-30
Completion
2020-07-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03678909 on ClinicalTrials.gov